Sufficient production of geranylgeraniol is required to maintain endotoxin tolerance in macrophages

Endotoxin tolerance allows macrophages to produce large quantities of proinflammatory cytokines immediately after their contact with lipopolysaccharides (LPSs), but prevents their further production after repeated exposure to LPSs. While this response is known to prevent overproduction of proinflammatory cytokines, the mechanism through which endotoxin tolerance is established has not been identified. In the current study, we demonstrate that sufficient production of geranylgeraniol (GGOH) in macrophages is required to maintain endotoxin tolerance. We show that increased synthesis of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) protein following LPS treatment is required to produce enough GGOH to inhibit expression of Malt1, a protein known to stimulate expression of proinflammatory cytokines, in macrophages repeatedly exposed to LPSs. Depletion of GGOH caused by inhibition of HMGCR led to increased Malt1 expression in macrophages subjected to repeated exposure to LPSs. Consequently, endotoxin tolerance was impaired, and production of interleukin 1-β and other proinflammatory cytokines was markedly elevated in these cells. These results suggest that insufficient production of GGOH in macrophages may cause autoinflammatory diseases.

[1]  Yusuke Ohsaki,et al.  Dietary supplementation with geranylgeraniol suppresses lipopolysaccharide-induced inflammation via inhibition of nuclear factor-κB activation in rats , 2013, European Journal of Nutrition.

[2]  Andrew C. Li,et al.  Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses , 2012, Cell.

[3]  R. Sen.  The origins of NF-κB , 2011, Nature Immunology.

[4]  S. Young,et al.  Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. , 2011, Cell metabolism.

[5]  T. Osborne,et al.  Liver x receptors in atherosclerosis and inflammation. , 2011, Circulation research.

[6]  M. Bergo,et al.  Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. , 2011, The Journal of clinical investigation.

[7]  Eoin Fahy,et al.  A Mouse Macrophage Lipidome*♦ , 2010, The Journal of Biological Chemistry.

[8]  Eoin Fahy,et al.  Subcellular organelle lipidomics in TLR-4-activated macrophages1[S] , 2010, Journal of Lipid Research.

[9]  P. Thompson,et al.  The genetics of statin-induced myopathy. , 2010, Atherosclerosis.

[10]  D. Kastner,et al.  Autoinflammatory Disease Reloaded: A Clinical Perspective , 2010, Cell.

[11]  W. Kuis,et al.  Systemic JIA: new developments in the understanding of the pathophysiology and therapy. , 2009, Best practice & research. Clinical rheumatology.

[12]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[13]  Zhijian J. Chen,et al.  The role of ubiquitin in NF-kappaB regulatory pathways. , 2009, Annual review of biochemistry.

[14]  Xia Zhang,et al.  The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.

[15]  M. Thome.  Multifunctional roles for MALT1 in T-cell activation , 2008, Nature Reviews Immunology.

[16]  H. Dolznig,et al.  Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. , 2007, RNA.

[17]  H. Waterham,et al.  A role for geranylgeranylation in interleukin‐1β secretion , 2006 .

[18]  Christopher M. Adams,et al.  Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs* , 2004, Journal of Biological Chemistry.

[19]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[20]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Waterham,et al.  Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation , 2003, Cellular and Molecular Life Sciences CMLS.

[22]  J. Cavaillon,et al.  Endotoxin tolerance: is there a clinical relevance? , 2003, Journal of endotoxin research.

[23]  H. Waterham,et al.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. , 2002, Arthritis and rheumatism.

[24]  R. Hammer,et al.  Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c* , 2002, The Journal of Biological Chemistry.

[25]  R. Wanders,et al.  Biochemical and genetic aspects of mevalonate kinase and its deficiency. , 2000, Biochimica et biophysica acta.

[26]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[27]  H. Waterham,et al.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.

[28]  L. Brissette,et al.  Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels. , 1991, The Journal of biological chemistry.

[29]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[30]  M. Nakanishi,et al.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. , 1988, The Journal of biological chemistry.

[31]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. , 1983, The Journal of biological chemistry.

[32]  J. Porter,et al.  Biosynthesis of Isoprenoid Compounds , 1983 .

[33]  Joseph L Goldstein,et al.  Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. , 2006, Cell metabolism.

[34]  J. Goldstein,et al.  Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. , 2003, Molecular cell.

[35]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.